Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety

31,281 participants from 1,124 studies who received IV angiotensin II, including healthy subjects, pregnant women, and patients with various medical conditions (e.g., cardiovascular, renal, hepatic, pulmonary diseases, and shock).

IV angiotensin II (doses ranging from 0.5 to 3,780 ng/kg/min)

Safety and adverse eventssafety